Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06656897 · ClinicalTrials.gov registry record · Early Phase 1
Preliminary Clinical Trial- FallScape-D
A Early Phase 1 study of Falls, sponsored by Brookside Research & Development Company.
- Active
- Registry status
- Early Phase 1
- Development phase
- 24
- Enrollment target
- 1
- Study location
NCT06656897: Active Early Phase 1 study of Falls, sponsored by Brookside Research & Development Company.
NCT06656897 is a Early Phase 1 study of Falls that is active but no longer recruiting, run by Brookside Research & Development Company. The registered enrollment target is 24 participants, below the 227-participant average among 7 other Falls trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06656897, a Early Phase 1 study of Falls, is active but no longer recruiting, sponsored by Brookside Research & Development Company.
- ACTIVE NOT RECRUITING
- Registry status
- Early Phase 1
- Development phase
- 24 participants
- Enrollment target
- 1
- Study location
Study Summary
Falls are a common and expensive problem, especially in persons with cognitive impairment due to Alzheimer's Disease and Related Dementias (PwADRD). The annual cost of falls is approximately 70 billion dollars, and falls add to the burden of a family caregiver. Injurious falls are a frequent reason people are unable to remain at home, resulting in significantly increased care costs to the family and society. Most falls prevention efforts fail to address the understanding of fall risks, or the need to change the behavior of the PwADRD, the caregiver, or both. In response to a National Institute on Aging request for 'Care technology to sustain in-home living, preserve function and promote effective communication', an innovative falls prevention intervention for use by caregivers of PwADRD who are still living at home and classified as at moderate to high risk for falls will be developed and tested. This new technology is called FallScape for Dementia (FS-D). The innovative caregiver-provided daily treatment uses an engaging multimedia approach and behavioral intervention methods to facilitate communication and encourage change in falls prevention behaviors to reduce PwADRD falls. This new FS-D intervention offers the rare opportunity to empower both the caregiver and the Person with memory loss by breaking the frustrating cycle of failure to recognize what could make an individual fall, or change behavior and may mitigate the burden that results from falls. FS-D is an urgently needed falls prevention intervention for family caregiver use. The economic and quality of life benefits of sustaining in-home living by preventing falls will benefit not only the caregiver and family, but will accrue to all stakeholders for this large, high-risk population.
Primary Outcome
Ten standardized video clips (less than 30 sec. each) are randomized and the first five are shown for the Pre-test; the second five video clips are shown for the Post-test. For each video clip, the PwADRD is asked "What do you notice that could cause a fall?" and each response is documented.
Conditions Studied
Interventions
- BEHAVIORAL FallScape for Persons with Alzheimer's disease or a related Dementia (FS-D)
Study Locations (1)
Washington
- Brookside Research & Development - Coupeville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2024-03-12 |
| Est. Completion | 2024-12-31 |
| Phase | Early Phase 1 |
What the registry record for NCT06656897 still lists
NCT06656897 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 24 participants, a relatively small participant target, below the 227-participant average among 7 other Falls trials with a reported enrollment target (89% lower).
The record links to 1 condition, with Falls appearing as the primary indexed condition, and to 1 intervention - of which FallScape for Persons with Alzheimer's disease or a related Dementia (FS-D) is the first listed.
NCT06656897 reports a single indexed study location in Washington.
Frequently Asked Questions
What is clinical trial NCT06656897 about?
NCT06656897 is a clinical study titled "Preliminary Clinical Trial- FallScape-D". Falls are a common and expensive problem, especially in persons with cognitive impairment due to Alzheimer's Disease and Related Dementias (PwADRD). The annual cost of falls is approximately 70 billion dollars, and falls add to the burden of a family caregiver. Injurious falls are a frequent reason ...
What is the current status of trial NCT06656897?
This trial is currently active not recruiting. It is a Early Phase 1 study. The enrollment target is 24 participants. The study started on 2024-03-12. Estimated completion is 2024-12-31.
What conditions does trial NCT06656897 study?
This clinical trial studies the following conditions: Falls.
What interventions are being tested in trial NCT06656897?
The interventions under investigation include: FallScape for Persons with Alzheimer's disease or a related Dementia (FS-D) (BEHAVIORAL).
Who is sponsoring clinical trial NCT06656897?
This trial is sponsored by Brookside Research & Development Company, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06656897 being conducted?
This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Falls
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Adapting, Implementing and Evaluating the Effectiveness of HARP for People With Disabilities
RECRUITING · NA
-
How's Your Balance?
ACTIVE NOT RECRUITING
-
Reducing Fall Risk With NMES
ACTIVE NOT RECRUITING · NA
-
Orthostatic Hypotension Treatment on Rehab Unit
COMPLETED · NA
-
A Pilot Study of the Impact of Vitamin D3 on Muscle Performance in Elderly Women
COMPLETED · NA
-
Postural Effects of Being Rotated in a Whole Body Gyroscope
COMPLETED
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02331979 · 24 participants · NA
Improving Bladder Function in SCI by Neuromodulation
- NCT03096197 · 24 participants · NA
Exoskeleton and Spinal Cord Stimulation for SCI
- NCT03223922 · 24 participants · NA
Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases
- NCT03326921 · 24 participants · Phase 1
HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI